Fighting Blindness Canada research

First Patients Treated in XLRP Gene Therapy Trial

Beacon Therapeutics, has announced that they have treated the first patients in their Phase 2/3 VISTA trial for a gene therapy for X-linked...

Read More
Fighting Blindness Canada

New Gene Replacement Clinical Trial Launched for RP Test

ViGeneron in Munich, Germany has launched a new Phase 1b clinical trial testing a novel gene replacement therapy in individuals affected by...

Read More
Fighting Blindness Canada

New Treatment Target for AMD Identified

For people living with wet age-related macular degeneration (AMD), the first line of treatment is anti-VEGF injections Anti-VEGF injections have...

Read More
Close-up of a phoropter, a piece of optometry technology used for eye testing, showing numerous lenses and dials for vision correction assessment.

Lessons From a Superfield Lens

By Dr Jenny Lee, OD Aperture Contest Winner Aperture is the publication of the Canadian Association of Optometry Students Reprinted with...

Read More
Fighting Blindness Canada research

Oral Drug Slows Stargardt Disease Progression in Phase 2 Clinical Trial

Results from a Phase 2 clinical trial show that an oral drug, Tinlarebant, may slow progression of Stargardt disease Belite Bio, a...

Read More
1 4 5 6 7 8 52